Survival and Lates Effects of JPLT (Japanese Study Group for Rediatric Liver Tumor)-2 Risk-Stratified Study for Hepatoblastoma

被引：0
|
作者：
Hiyama, E. [1 ]
Hishiki, T. [2 ]
Ida, K. [2 ]
Watanabe, K. [2 ]
Tanaka, Y. [2 ]
Aoki, Y. [2 ]
Iehara, T. [2 ]
Kazama, T. [2 ]
Kihira, K. [2 ]
Taguchi, T. [2 ]
Fujimura, J. [2 ]
Hoshino, K. [2 ]
Honda, S. [2 ]
Matsumoto, K. [2 ]
Mori, M. [2 ]
Yano, M. [2 ]
机构：
[1] Hiroshima Univ Hosp, Peditr Surg, Hiroshima, Japan
[2] Japanese Children Canc Grp, Liver Tumor Comm, Tokyo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-126
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [31] Differentiated treatment protocols for high- and standard-risk hepatoblastoma -: An interim report of the German liver tumor study HB 99
    Häberle, B
    Bode, U
    von Schweinitz, D
    KLINISCHE PADIATRIE, 2003, 215 (03): : 159 - 165
  • [32] ROLE OF RADIOTHERAPY IN HEPATOBLASTOMA AND HEPATOCELLULAR-CARCINOMA IN CHILDREN AND ADOLESCENTS - RESULTS OF A SURVEY CONDUCTED BY THE SIOP LIVER-TUMOR STUDY-GROUP
    HABRAND, JL
    PRITCHARD, J
    MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (03): : 208 - 208
  • [33] Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study
    Veeratterapillay, Rajan
    Geraghty, Robert
    Pandian, Rajadoss
    Roy, Chloe
    Stenhouse, Georgie
    Bird, Clare
    Soomro, Naeem
    Paez, Edgar
    Rogers, Alistair
    Johnson, Mark
    Page, Toby
    Rix, David
    Thomas, David
    Rai, Bhavan Prasad
    BJU INTERNATIONAL, 2022, 129 (06) : 744 - 751
  • [34] A PHASE 2 STUDY OF THE BTK INHIBITOR IBRUTINIB IN GENETIC RISK-STRATIFIED RELAPSED AND REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL)
    Maddocks, K.
    Flynn, J. M.
    Andritsos, L. A.
    Awan, F.
    Woyach, J. A.
    Grever, M. R.
    Stefanos, M.
    Lynch, J.
    Johnson, A. J.
    Byrd, J. C.
    Jones, J. A.
    HAEMATOLOGICA, 2014, 99 : 522 - 522
  • [35] Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group
    Takaki, Shintaro
    Kurosaki, Masayuki
    Mori, Nami
    Tsuji, Keiji
    Ochi, Hironori
    Marusawa, Hiroyuki
    Nakamura, Shinichiro
    Tada, Toshifumi
    Narita, Ryoichi
    Uchida, Yasushi
    Akahane, Takehiro
    Kondo, Masahiko
    Kusakabe, Atsunori
    Furuta, Koichiro
    Kobashi, Haruhiko
    Arai, Hirotaka
    Nonogi, Michiko
    Tamada, Takashi
    Hasebe, Chitomi
    Ogawa, Chikara
    Sato, Takashi
    Tamaki, Nobuharu
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Izumi, Namiki
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (02) : 340 - 349
  • [36] Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group
    Shintaro Takaki
    Masayuki Kurosaki
    Nami Mori
    Keiji Tsuji
    Hironori Ochi
    Hiroyuki Marusawa
    Shinichiro Nakamura
    Toshifumi Tada
    Ryoichi Narita
    Yasushi Uchida
    Takehiro Akahane
    Masahiko Kondo
    Atsunori Kusakabe
    Koichiro Furuta
    Haruhiko Kobashi
    Hirotaka Arai
    Michiko Nonogi
    Takashi Tamada
    Chitomi Hasebe
    Chikara Ogawa
    Takashi Sato
    Nobuharu Tamaki
    Yutaka Yasui
    Kaoru Tsuchiya
    Namiki Izumi
    Investigational New Drugs, 2023, 41 : 340 - 349
  • [37] A genetic risk-stratified, randomized phase 2 intergroup study of fludarabine/antibody combinations in symptomatic, untreated chronic lymphocytic leukemia (CLL): Results from Cancer and Leukemia Group B (CALGB) 10404 (Alliance).
    Ruppert, Amy S.
    Byrd, John C.
    Heerema, Nyla A.
    Smith, Mitchell Reed
    Godwin, John E.
    Couban, Stephen
    Fehniger, Todd A.
    Thirman, Michael
    Halvorson, Alese E.
    Tallman, Martin S.
    Appelbaum, Frederick R.
    Stone, Richard M.
    Robinson, Sue
    Chang, Julie E.
    Mandrekar, Sumithra J.
    Larson, Richard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Excellent outcome of risk stratified treatment for childhood acute myeloid leukemia-AML99 trial - For the Japanese Childhood AML Cooperative Study Group
    Tsukimoto, I
    Tawa, A
    Hanada, R
    Tabuchi, K
    Kigasawa, H
    Tsuchiya, S
    Tsuchida, M
    Yabe, H
    Nakayama, H
    Kudo, K
    Kobayashi, R
    Hamamoto, K
    Imaizumi, M
    Morimoto, A
    Horibe, K
    BLOOD, 2005, 106 (11) : 261A - 261A
  • [39] Surgical view of the treatment of patients with hepatoblastoma - Results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group (SIOPEL-1)
    Schnater, JM
    Aronson, DC
    Plaschkes, J
    Perilongo, G
    Brown, J
    Otte, JB
    Brugieres, L
    Czauderna, P
    MacKinlay, G
    Vos, A
    CANCER, 2002, 94 (04) : 1111 - 1120
  • [40] Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy:: Results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Miinster Group 87
    Einsiedel, HG
    von Stackelberg, A
    Hartmann, R
    Fengler, R
    Schrappe, M
    Janka-Schaub, G
    Mann, G
    Hählen, K
    Göbel, U
    Klingebiel, T
    Ludwig, WD
    Henze, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 7942 - 7950
12345